Compare CAH & CBRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CAH | CBRE |
|---|---|---|
| Founded | 1979 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.1B | 50.7B |
| IPO Year | N/A | 2004 |
| Metric | CAH | CBRE |
|---|---|---|
| Price | $223.99 | $142.43 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 7 |
| Target Price | ★ $229.09 | $179.00 |
| AVG Volume (30 Days) | 1.8M | ★ 2.5M |
| Earning Date | 02-05-2026 | 02-12-2026 |
| Dividend Yield | ★ 0.93% | N/A |
| EPS Growth | ★ 29.45 | 22.61 |
| EPS | ★ 6.94 | 3.85 |
| Revenue | ★ $244,673,000,000.00 | $40,550,000,000.00 |
| Revenue This Year | $16.99 | $12.38 |
| Revenue Next Year | $9.27 | $8.49 |
| P/E Ratio | ★ $31.79 | $36.96 |
| Revenue Growth | 10.08 | ★ 13.37 |
| 52 Week Low | $120.72 | $108.45 |
| 52 Week High | $230.81 | $174.27 |
| Indicator | CAH | CBRE |
|---|---|---|
| Relative Strength Index (RSI) | 58.12 | 31.32 |
| Support Level | $213.75 | $125.78 |
| Resistance Level | $229.15 | $174.27 |
| Average True Range (ATR) | 7.01 | 8.11 |
| MACD | 0.17 | -3.55 |
| Stochastic Oscillator | 74.89 | 34.66 |
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
CBRE Group provides a wide range of real estate services to owners, occupants, and investors worldwide, including leasing, property and project management, and capital markets advisory. CBRE's investment management arm manages over $140 billion for clients across diverse public and private real estate strategies.